Mian M K Shahzad
Overview
Explore the profile of Mian M K Shahzad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
2319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Matsuo K, Cripe J, Kurnit K, Kaneda M, Garneau A, Glaser G, et al.
Gynecol Oncol
. 2019 Aug;
155(1):39-50.
PMID: 31427143
Objective: To examine the association between ovarian conservation and oncologic outcome in surgically-treated young women with early-stage, low-grade endometrial cancer. Methods: This multicenter retrospective study examined women aged <50 with...
12.
Matsuo K, Takazawa Y, Ross M, Elishaev E, Yunokawa M, Sheridan T, et al.
Surg Oncol
. 2018 Sep;
27(3):433-440.
PMID: 30217299
Objective: To examine significance of sarcoma dominance (SD) patterns in uterine carcinosarcoma (UCS). Methods: This is a secondary analysis of multicenter retrospective study examining women with stages I-IV UCS who...
13.
Matsuo K, Takazawa Y, Ross M, Elishaev E, Yunokawa M, Sheridan T, et al.
Ann Surg Oncol
. 2018 Aug;
25(12):3676-3684.
PMID: 30105438
Purpose: To propose a categorization model of uterine carcinosarcoma (UCS) based on tumor cell types (carcinoma and sarcoma) and sarcoma dominance. Methods: This secondary analysis of a prior multicenter retrospective...
14.
Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma
Matsuo K, Takazawa Y, Ross M, Elishaev E, Yunokawa M, Sheridan T, et al.
Ann Surg Oncol
. 2018 Jul;
25(9):2756-2766.
PMID: 29971677
Objective: The aim of this study was to examine the significance of lymphovascular space invasion (LVSI) with a sarcomatous component on the tumor characteristics and clinical outcomes of women with...
15.
Shahzad M, Arevalo J, Armaiz-Pena G, Lu C, Stone R, Moreno-Smith M, et al.
J Biol Chem
. 2018 Jul;
293(26):10041.
PMID: 29959278
No abstract available.
16.
Shahzad M, Felder M, Ludwig K, Van Galder H, Anderson M, Kim J, et al.
PLoS One
. 2018 Jan;
13(1):e0189524.
PMID: 29324748
The goal of this study was to investigate the anti-cancer effects of Trans10,cis12 conjugated linoleic acid (t10,c12 CLA). MTT assays and QCM™ chemotaxis 96-wells were used to test the effect...
17.
Matsuo K, Ross M, Im D, Klobocista M, Bush S, Johnson M, et al.
Gynecol Oncol
. 2017 Dec;
148(2):267-274.
PMID: 29248197
Objective: To identify risk factors for venous thromboembolism (VTE) and to examine the association of VTE and survival in women with uterine carcinosarcoma. Methods: This multicenter retrospective study examined 906...
18.
Noh K, Mangala L, Han H, Zhang N, Pradeep S, Wu S, et al.
Cell Rep
. 2017 Dec;
21(10):2785-2795.
PMID: 29212026
Angiogenesis inhibitors are important for cancer therapy, but clinically approved anti-angiogenic agents have shown only modest efficacy and can compromise wound healing. This necessitates the development of novel anti-angiogenesis therapies....
19.
Matsuo K, Ross M, Yunokawa M, Johnson M, Machida H, Omatsu K, et al.
Gynecol Oncol
. 2017 Oct;
147(3):565-571.
PMID: 29056442
Objective: To examine survival after recurrence (SAR) among women with recurrent uterine carcinosarcoma who received a taxane/platinum doublet as the first-line salvage chemotherapy. Methods: We retrospectively examined 148 women with...
20.
Matsuo K, Johnson M, Im D, Ross M, Bush S, Yunokawa M, et al.
J Surg Oncol
. 2017 Oct;
117(3):488-496.
PMID: 29044542
Background And Objectives: To examine survival of women with stage IV uterine carcinosarcoma (UCS) who received neoadjuvant chemotherapy followed by hysterectomy. Methods: This is a nested case-control study within a...